Hospital Uversitari de Bellvitge
Barcelona, 08907, Spain
Location status: Recruiting
Location contact
Mònica Miró
CONTACT
Rodrigo Hermoza
CONTACT
NCT Number: NCT05802459
The goal of this prospective population-based cohort study is to assess:
* The evolution of the functional status of patients undergoing complex esophageal reconstruction * Its impact on quality of life, depending on the type of conduit performed.
Participants
* Will be asked to complete different quality of life questionnaires during every follow-up visit * Will undergo additional tests to assess functionality
Interested in participating?
Request Info18 year and older
All sexes
Observational
Barcelona, 08907, Spain
Location status: Recruiting
Mònica Miró
CONTACT
Rodrigo Hermoza
CONTACT
-General Justification: In recent years, esophageal reconstruction has been a great surgical challenge for the multidisciplinary teams in charge of carrying out this complex technique, associated with high morbidity and a high impact on the quality of life and functional status of patients.
One of the most important aspects of this surgery is the type of conduit used to restore digestive transit. Classically, gastroplasty has been the technique of choice due to its lower morbidity and mortality and less surgical complexity. On the other hand, in those patients in whom the stomach is not available, a coloplasty or a jejunoplasty is chosen, both of which can be associated with supercharged techniques to improve and ensure good vascular flow.
Currently, there is controversy about which type of conduit to use in the absence of a viable stomach. Since the introduction of microvascular or supercharged techniques, the postoperative results of jejunal grafts are comparable to coloplasty and even gastroplasty according to some authors.
The present study is an initiative of the Complex Esophageal Reconstruction Unit (UREC) of Bellvitge University Hospital (HUB), which aims to compare the different types of conduit used in complex esophageal reconstruction, assessing, in the short and long term, the postoperative functional status and its impact on quality of life through validated test-type tools, as well as carrying out complementary tests that allow evaluating aspects such as swallowing and dysphagia, among others.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
central generic questionnaire associated with different disease specific modules
module to assess the quality of life in patients with esophagogastric disease.
Gastrointestinal Quality of Life Index. It is a gastrointestinal quality of life scale.
Swallowing Quality of Life questionnaire. This is a quality of life and quality of attention questionnaire for patients with oropharyngeal dysphagia.
It consists of 14 items that represent the oral and pharyngeal function observed in the VDF. It allows to quantify the severity of dysphagia.
Time frame: The follow-up of each patient included in the study will end 3 years after the intervention when the End of Study visit will be carried out.
This study aims to determine the differences in the quality of life of patients undergoing complex esophageal reconstruction by jejunoplasty (free, pedunculated ± supercharged) or coloplasty (± supercharged) using the following questionnaires:
Time frame: The follow-up of each patient included in the study will end 3 years after the intervention when the End of Study visit will be carried out.
This study aims to describe the functional evolution of complex esophageal reconstruction by jejunoplasty (free, pedunculated ± supercharged) or coloplasty (± supercharged).
Time frame: The follow-up of each patient included in the study will end 3 years after the intervention when the End of Study visit will be carried out.
Incidence of dysphagia evaluated by Videofluoroscopic (VDF) using the following scales:
Time frame: The follow-up of each patient included in the study will end 3 years after the intervention when the End of Study visit will be carried out.
Incidence of stenosis of the conduit in the Upper Digestive Endoscopy (UDE) that requires some therapeutic maneuver (dilatation), which is carried out during the follow-up visits: one year, two and three years.
Time frame: The follow-up of each patient included in the study will end 3 years after the intervention when the End of Study visit will be carried out.
Number (percentage) of dilatations of the conduit, per patient, carried out during the UDE within the follow-up visits: one year, two and three years.
Time frame: The follow-up of each patient included in the study will end 3 years after the intervention when the End of Study visit will be carried out.
Number (percentage) of patients with esophagitis according to the Los Angeles classification evidenced in any of the UDE performed during the follow-up visits: one year, two and three years.
Time frame: The follow-up of each patient included in the study will end 3 years after the intervention when the End of Study visit will be carried out.
Number (percentage) of patients with chronic diarrhea during follow-up
Time frame: The follow-up of each patient included in the study will end 3 years after the intervention when the End of Study visit will be carried out.
Weight and height will be combined to report Body Mass Index (BMI kg/m2) as a measure for indicating nutritional status
Time frame: The follow-up of each patient included in the study will end 3 years after the intervention when the End of Study visit will be carried out.
Handgrip strength expressed in Kg and assessed using the reference values for age and sex
Time frame: The follow-up of each patient included in the study will end 3 years after the intervention when the End of Study visit will be carried out.
Measure of albumin/prealbumin in blood tests for assessment of nutritional status. Normal value: 34 - 54 g/L
Time frame: The follow-up of each patient included in the study will end 3 years after the intervention when the End of Study visit will be carried out.
Mean 'time of need for enteral nutrition and oral nutrition supplements' during the post-surgical follow-up period.
Time frame: The follow-up of each patient included in the study will end 3 years after the intervention when the End of Study visit will be carried out.
Volume of enteral nutrition required during the post-surgical follow-up period.
Time frame: The follow-up of each patient included in the study will end 3 years after the intervention when the End of Study visit will be carried out.
Number of hospitalizations, for any reason, during the post-surgical follow-up period.
Time frame: The follow-up of each patient included in the study will end 3 years after the intervention when the End of Study visit will be carried out.
Number (percentage) of specific complications of the surgery during admission according to the Esophageal Complication Consensus Group (ECCG) (20), highlighting anastomotic dehiscence, surgical site infection, bleeding, need for reintervention, ischaemia of the graft (up to 90 ±3 days after surgery). Number (percentage) of complications according to the Clavien-Dindo classification (21) and Comprehensive Complication Index.
Time frame: The follow-up of each patient included in the study will end 3 years after the intervention when the End of Study visit will be carried out.
Number (percentage) of deaths related to esophageal reconstruction (Up to 90 ±3 days after surgery).
Contact information is provided by the study sponsor or research team.
Monica Miró
CONTACT
Rodrigo Hermoza
CONTACT
Hospital Universitari de Bellvitge
Other
Prospective Evaluation of the Functional Status of Jejunoplasty and Coloplasty in Patients Undergoing Complex Esophageal Reconstruction and Its Impact on Quality of Life (CEREC)
Acronym: CEREC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04584658
COVID-19, Coronaviridae Infections
Cambridge, United Kingdom
View Trial DetailsNCT06407570
Deglutition Disorders, Digestive System Diseases
Aarhus, Denmark
View Trial DetailsNCT03476265
Deglutition Disorders, Digestive System Diseases
Vienna, Austria
View Trial DetailsNCT03889041
Deglutition Disorders, Digestive System Diseases
Ankara, Turkey (Türkiye)
View Trial Details